Local and systemic hemostatics as an adjunct to control bleeding in trauma.

Publisher: SAGE Publications in association with Southeastern Surgical Congress Country of Publication: United States NLM ID: 0370522 Publication Model: Print Cited Medium: Internet ISSN: 1555-9823 (Electronic) Linking ISSN: 00031348 NLM ISO Abbreviation: Am Surg Subsets: MEDLINE

Publication: 2020- : [Thousand Oaks, CA] : SAGE Publications in association with Southeastern Surgical Congress
Original Publication: Atlanta Ga : Southeastern Surgical Congress

Hemorrhage/*drug therapy ; Hemostatics/*therapeutic use ; Wounds and Injuries/*complications; Administration, Topical ; Cellulose, Oxidized/therapeutic use ; Chitosan/therapeutic use ; Combined Modality Therapy ; Factor VIIa/therapeutic use ; Fibrin Tissue Adhesive/therapeutic use ; Hemorrhage/etiology ; Hemorrhage/therapy ; Hemostatic Techniques ; Humans ; Recombinant Proteins/therapeutic use ; Tissue Adhesives/therapeutic use ; Tranexamic Acid/therapeutic use ; Zeolites/therapeutic use

Although surgical and angiointervention techniques remain the cornerstone for the management of severe bleeding after trauma, adjunct therapeutic strategies such as local or systemic hemostatic agents can play an important role. This article reviews the role and efficacy of the available hemostatic agents.

0 (Cellulose, Oxidized)
0 (Fibrin Tissue Adhesive)
0 (Hemostatics)
0 (Recombinant Proteins)
0 (Tissue Adhesives)
1318-02-1 (Zeolites)
6T84R30KC1 (Tranexamic Acid)
82347-53-3 (Surgicel)
9012-76-4 (Chitosan)
AC71R787OV (recombinant FVIIa)
EC 3.4.21.21 (Factor VIIa)

Date Created: 20130123 Date Completed: 20130318 Latest Revision: 20161125

20240829

23336658